There is no approved treatment for high Lp(a), but five drugs are in development, and last fall, two of them – Muvalaplin and Zerlasiran – moved a step closer to consideration by the FDA. Muvalaplin performed so well in a phase II trial (lowering levels by 86%) that its lead researcher expressed surprise. Jan 21, 2025.
In the meantime, an Epidemiological study determined that Vitamin C and Lysine kept LP (a) from making LDL more sticky. My LP a was not overly out of range, but after 5 years on the above 2 supplements it has greatly improved.